PhoenixMD and WuXi STA Ready for Cancer Trial

11.06.2019 - Canadian biotech company Phoenix Molecular Designs (PhoenixMD) and partner STA Pharmaceutical (WuXi STA), a Chinese contract development and manufacturing organization (CDMO), have...